Constanze Hantel

12PUBLICATIONS
75CO-AUTHORS
Molecular targetsSolid tumoursCancer geneticsOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 13, 2026
Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas.

|Jan 13, 2026
A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone, 18-oxocortisol and 18-hydroxycortisol.

Igor Shapiro, Chiara Kräuchi, Edlira Luca

|Jan 12, 2026
Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection.

Alessa Fischer, Hanna Remde, Christina Pamporaki

|Jan 10, 2026
Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms.

Christoph J Auernhammer, Katharina Wang, Umberto Maccio

|Dec 15, 2025
Rising Incidence of Neuroendocrine Neoplasms in Northern Switzerland-Data From the Cancer Registry.

Alessa Fischer, Miriam Wanner, Flurina Suter

|Oct 23, 2025
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours.

Katharina Wang, Christoph J Auernhammer, Simon Lindner

Pageof 2

Frequent Collaborators

5 joint publications

Svenja Nölting

5 joint publications

Katharina Wang

5 joint publications

Felix Beuschlein

4 joint publications

Alessa Fischer